postpartum-hemorrhage

Documents about postpartum-hemorrhage

• Safety and Effectiveness of the Alma System in Treating Primary Postpartum Hemorrhage#67714ClinicalTrials.gov
• Postpartum Hemorrhage After Shenghua Decoction Treatment#883776ClinicalTrials.gov
• Uterine Tamponade for Treatment of Primary Postpartum Hemorrhage#877920ClinicalTrials.gov
• Obstetric Comorbidity Index in Postpartum Hemorrhage#253124ClinicalTrials.gov
• Amr's Maneuver and Postpartum Hemorrhage#801646ClinicalTrials.gov
• Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage#900198ClinicalTrials.gov
• Fever After Misoprostol Administration for the Treatment of Primary Postpartum Hemorrhage#890814ClinicalTrials.gov
• Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage#888667ClinicalTrials.gov
• Postpartum Video Education#201674ClinicalTrials.gov
• Kenya: The Barriers and Facilitators of Scaling up the Ellavi UBT for Postpartum Hemorrhage#1030339ClinicalTrials.gov
• Risk Factors for Postpartum Hemorrhage#862141ClinicalTrials.gov
• Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage#868291ClinicalTrials.gov
• Risk Factors for Postpartum Hemorrhage in Patients With Histologically Verified Placenta Accreta#217160ClinicalTrials.gov
• Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage#804182ClinicalTrials.gov
• Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial#873011ClinicalTrials.gov
• Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.#884919ClinicalTrials.gov
• Tranexamic Acid Pharmacokinetics During Postpartum Hemorrhage#810779ClinicalTrials.gov
• Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery#828454ClinicalTrials.gov
• The Effect of Game-Based Learning and Telesimulation on Nursing Students' Management of Postpartum Hemorrhage#807934ClinicalTrials.gov
• Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa#856444ClinicalTrials.gov
• Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section#865000ClinicalTrials.gov
• Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities#904976ClinicalTrials.gov
• Immediate vs Delayed Postpartum Implanon-NXT#861871ClinicalTrials.gov
• Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage#854176ClinicalTrials.gov
• Family history of postpartum hemorrhage is a risk factor for postpartum hemorrhage after vaginal delivery: results from the French prospective multicenter Haemorrhages and Thromboembolic Venous Disease of the Postpartum cohort study#971170HAL (France)
• Study of Biological Determinants of Bleeding Postpartum#842545ClinicalTrials.gov
• Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage#807930ClinicalTrials.gov
• Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery#971229HAL (France)
• Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care#981331ClinicalTrials.gov
• Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage#880460ClinicalTrials.gov
• Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan#877816ClinicalTrials.gov
• Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India#893578ClinicalTrials.gov
• Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT)#903849ClinicalTrials.gov
• Prevention of Postpartum Hemorrhage With Tranexamic Acid#913320ClinicalTrials.gov
• The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)#839141ClinicalTrials.gov
• TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery#893464ClinicalTrials.gov
• Interest of TEG6S® in Reducing Transfusion Needs During Postpartum Haemorrhage#831237ClinicalTrials.gov
• Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in Ghana#966185ClinicalTrials.gov
• Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin#899926ClinicalTrials.gov
• Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT#825281ClinicalTrials.gov
• Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India#898306ClinicalTrials.gov
• A Novel Tourniquet Technic for Massive PPH#854524ClinicalTrials.gov
• Evaluating Postpartum Hemorrhage Transfusion Risk With a Machine Learning Model for Informed Consent: Retrospective Cohort Study.#275973PubMed
• Intrauterine Balloon (Bakri©) Versus Uterine Tamponade With Chitosan Gauze (Celox PPH©) in the Management of Postpartum Hemorrhage Refractory to Medical Treatmen#901703ClinicalTrials.gov
• Development and Validation of a Predictive Tool for Postpartum Hemorrhage after Vaginal Delivery: A Prospective Cohort Study#983835HAL (France)
• Feasibility Clinical Investigation Using the InPress Device for the Treatment of Postpartum Hemorrhage#1010420ClinicalTrials.gov
• rhuFVIIa in Post-partum Hemorrhage#981699ClinicalTrials.gov
• Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section#807395ClinicalTrials.gov
• Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia#181630ClinicalTrials.gov
• Effect of Simulation-Based Postpartum Hemorrhage Training on Team Performance in Senior Anesthesiology Teams#878676ClinicalTrials.gov